Geriatric Pharmacology: Safe Prescribing & Beers Criteria

Added:

The Risk of Undertreatment and the Limitations of Rigid Checklist-Based Prescribing

While the Beers Criteria provide essential guidelines for preventing adverse drug events in older adults, critics argue that rigid, dogmatic adherence to these lists can lead to 'therapeutic nihilism' and the undertreatment of clinically valid conditions. The primary counter-perspective emphasizes that the Beers Criteria are population-level tools, not absolute contraindications. Strict enforcement—often driven by automated electronic health record alerts or rigid quality metrics—can override clinical judgment, discourage necessary prescribing, and fail to account for a patient's individual goals of care, quality of life, or palliative needs. For instance, withholding effective pain management, cardiovascular therapies, or psychotropic medications solely based on age-related criteria can cause unnecessary suffering. Therefore, proponents of this counter-perspective advocate for a balanced, patient-centered approach where clinical guidelines inform, rather than dictate, prescribing practices, ensuring that the fear of potential side effects does not overshadow the tangible benefits of personalized therapeutic intervention.

Basic principles of pharmacokinetics and pharmacodynamics (ADME processes) in a standard adult population.
Normal physiological changes associated with the aging process, particularly renal, hepatic, and cardiovascular decline.
The clinical concept of polypharmacy and the general mechanisms underlying drug-drug and drug-disease interactions.
Familiarity with common chronic conditions in older adults, such as cognitive impairment, hypertension, osteoarthritis, and sensory deficits.
Clinical application of the STOPP/START criteria as a companion tool to the Beers Criteria for medication optimization.
Structured protocols for safe deprescribing, including tapering schedules for high-risk medications like benzodiazepines and proton pump inhibitors.
Designing non-pharmacological management plans for common geriatric syndromes, such as chronic insomnia, anxiety, and behavioral symptoms of dementia.
Analyzing complex patient case studies featuring multimorbidity to balance guideline-directed medical therapy with geriatric safety guidelines.
1.6K views27likes56:58@WIFamilyMedicineOriginal Release: 2019-05-10

In elderly patients, drug distribution is most significantly affected by aging due to decreased body water (from ~70% to 40-50%) and increased adipose tissue, while absorption remains relatively unchanged; therefore, healthcare providers should minimize anticholinergic medications (such as diphenhydramine, oxybutynin, paroxetine, and certain SSRIs) which disproportionately affect cognition and increase delirium risk, avoid NSAIDs and COX-2 inhibitors due to cardiovascular and renal risks, limit proton pump inhibitors to 8 weeks to prevent hypomagnesemia and osteoporosis, and consult evidence-based guidelines like the Beers Criteria to identify inappropriate medications and optimize prescribing safety in older adults.